A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

HSV-1 disease is a significant public health burden causing orofacial, genital, cornea, and brain infection. We previously reported that a trivalent HSV-2 gC2, gD2, gE2 nucleoside-modified mRNA-lipid nanoparticle (LNP) vaccine provides excellent protection against vaginal HSV-1 infection in mice. He...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Kevin P. Egan, Sita Awasthi, Giulia Tebaldi, Lauren M. Hook, Alexis M. Naughton, Bernard T. Fowler, Mitchell Beattie, Mohamad-Gabriel Alameh, Drew Weissman, Gary H. Cohen, Harvey M. Friedman
פורמט: Article
שפה:English
יצא לאור: MDPI AG 2023-06-01
סדרה:Viruses
נושאים:
HSV-1
HSV-2
HSV vaccine
nucleoside-modified mRNA
oral herpes
genital herpes
גישה מקוונת:https://www.mdpi.com/1999-4915/15/7/1483

אינטרנט

https://www.mdpi.com/1999-4915/15/7/1483

פריטים דומים